
    
      A prospective, non-randomized, multi-center, single-arm clinical trial to evaluate the safety
      and efficacy of the RX HERCULINKâ„¢ 14 Peripheral Stent System in the treatment of suboptimal
      post- procedural percutaneous transluminal angioplasty (PTA) results in de novo or restenotic
      atherosclerotic renal artery stenoses.
    
  